dc.contributor.author
Garcia Garcia, Lucia
dc.contributor.author
Ollé, Laia
dc.contributor.author
Martín Andorrà, Margarita
dc.contributor.author
Roca i Ferrer, Jordi
dc.contributor.author
Muñoz-Cano, Rosa
dc.date.issued
2021-06-16T16:11:08Z
dc.date.issued
2021-06-16T16:11:08Z
dc.date.issued
2021-05-14
dc.date.issued
2021-06-16T16:11:08Z
dc.identifier
https://hdl.handle.net/2445/178411
dc.description.abstract
Adenosine is a nucleoside involved in the pathogenesis of allergic diseases. Its effects are mediated through its binding to G protein-coupled receptors: A1, A2a, A2b and A3. The receptors differ in the type of G protein they recruit, in the effect on adenylyl cyclase (AC) activity and the downstream signaling pathway triggered. Adenosine can produce both an enhancement and an inhibition of mast cell degranulation, indicating that adenosine effects on these receptors is controversial and remains to be clarified. Depending on the study model, A1, A2b, and A3 receptors have shown anti- or pro-inflammatory activity. However, most studies reported an anti-inflammatory activity of A2a receptor. The precise knowledge of the adenosine mechanism of action may allow to develop more efficient therapies for allergic diseases by using selective agonist and antagonist against specific receptor subtypes.
dc.format
application/pdf
dc.relation
Reproducció del document publicat a: https://doi.org/10.3390/ijms22105203
dc.relation
International Journal of Molecular Sciences, 2021, vol. 22, num. 10
dc.relation
https://doi.org/10.3390/ijms22105203
dc.rights
cc-by (c) Garcia Garcia, Lucia et al., 2021
dc.rights
https://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Biomedicina)
dc.title
Adenosine Signaling in Mast Cells and Allergic Diseases.
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion